Skip to main content

Publication, Part of

NICE Technology Appraisals in the NHS in England (Innovation Scorecard) To March 2020

Official statistics

Publication Date:
8 Oct 2020
Geographic Coverage:
England
Geographical Granularity:
Regions, Clinical Commissioning Groups, Sustainability and Transformation Partnerships, NHS Trusts
Date Range:
01 Apr 2016 to 31 Mar 2020

Current Chapter

NICE Technology Appraisals in the NHS in England (Innovation Scorecard) To March 2020

View all

Next Chapter

Background and Introduction
Page contents

Summary

The Innovation Scorecard reports on the use of medicines and medical technologies in the NHS in England, which have been positively appraised by the National Institute for Health and Care Excellence (NICE).

NHS Digital has produced and published the Innovation Scorecard as an Official Statistic since January 2013 on behalf of the Office for Life Sciences. It can be used by local NHS organisations to monitor progress in implementing NICE Technology Appraisal (TA) recommendations.

We produce the scorecard using a range of data sources prior to publication and no central data collection is involved.

Note:

Medical Technologies and Trust level purchase data are suspended pending a review of their inclusion criteria and available data sources as a result of developments by the Accelerated Access Collaborative.

Latest data to March 2020

What we measure and what we have found

Online Web Platform

Open the power BI dashboard. 

This tool is in Microsoft PowerBI which does not fully support all accessibility needs. You can find the source data on this page. If you need further assistance, please contact us for help.

Medicines

162 medicines 77% of medicines prescribed more

Medicines are those reported on the Innovation Scorecard only

Medicine Groupings

6 medicine groupings used to treat major conditions 5 medicine groupings were used more

Medicine groupings are those reported on the Innovation Scorecard only

For the 12 months from April 2019 to March 2020 (compared to the previous 12 months)

Reported as Defined Daily Doses (DDD), Actual Daily Doses (ADD), mgs, vials, tablets, units, implants, pads, interventions or pens/syringes per 100,000 population or QOF register in England

Conditions covered by medicine groupings:

  • Acute coronary syndrome
  • Diabetes
  • Hepatitis C
  • Multiple sclerosis
  • Stroke (Separate medicine groupings for stroke by care setting i.e. GP and hospital)

Source: NHS Digital

Key Facts

test

Administrative Sources

• English Prescribing Dataset (EPD) published by the NHS Business Services Authority • Secondary Care Medicines Data (SCMD) published by the NHS Business Services Authority • Hospital Episode Statistics (HES) data from NHS England • Population data from Office for National Statistics

Last edited: 5 July 2021 5:59 pm